Figure 6-6: Global – Forecast for Reclast/Aclasta Drug Sales (Million US$), 2011 – 2015 Figure 6-7: Global – Actonel Drug Sales (Million US$), 2004 – 2010 Figure 6-8: Global – Forecast for Actonel Drug Sales (Million US$), 2011 – 2013 Figure 6-10: Global – Evista Drug Sales (Million US$), 2001 – 2010 Figure 6-11: Global – Forecast for Evista Drug Sales (Million US$), 2011 – 2015 Figure 6-12: Global – Viviant/Conbriza Drug Sales (Million US$), 2010 – 2015 Figure 6-13: Global – Forteo Drug Sales (Million US$), 2003 – 2010 Figure 6-14: Global – Forecast for Forteo Drug Sales (Million US$), 2011 – 2015 Figure 6-15: Global – Miacalcin Drug Sales (Million US$), 2004 – 2010 Figure 6-16: Global – Forecast for Miacalcin Drug Sales (Million US$), 2011 – 2015 Figure 6-17: Global – Forecast for Prolia Drug (Million US$), 2010 – 2016 Figure 7-1: Global – Forecast for Odanacatib Drug (Million US$), 2012 – 2015 Figure 7-2: Global – Forecast for Aprela Drug Sales (Million US$), 2011 – 2015 Figure 9-1: Eli Lilly – Osteoporosis Drug Revenue (Million US$), 2007 – 2010 Figure 9-2: Roche – Osteoporosis Drug Revenue (Million US$), 2007 – 2010 Figure 9-3: Merck – Osteoporosis Drug Revenue (Million US$), 2007 – 2010 Figure 9-4: Novartis – Osteoporosis Drug Revenue (Million US$), 2007 – 2010


© Renub Research


Page 9 of 16


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16